1.81
Precedente Chiudi:
$1.70
Aprire:
$1.72
Volume 24 ore:
173.22K
Relative Volume:
0.47
Capitalizzazione di mercato:
$138.16M
Reddito:
$4.29M
Utile/perdita netta:
$-104.03M
Rapporto P/E:
-0.9195
EPS:
-1.9685
Flusso di cassa netto:
$-50.65M
1 W Prestazione:
+2.84%
1M Prestazione:
+33.09%
6M Prestazione:
+0.56%
1 anno Prestazione:
+12.42%
Cibus Inc Stock (CBUS) Company Profile
Nome
Cibus Inc
Settore
Industria
Telefono
(858) 450-0008
Indirizzo
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS vs VRTX, REGN, ARGX, RVMD, ALNY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CBUS
Cibus Inc
|
1.81 | 129.76M | 4.29M | -104.03M | -50.65M | -1.9685 |
|
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
|
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-29 | Iniziato | Alliance Global Partners | Buy |
| 2024-07-19 | Ripresa | Canaccord Genuity | Buy |
| 2023-10-09 | Iniziato | H.C. Wainwright | Buy |
| 2023-07-19 | Ripresa | Canaccord Genuity | Buy |
Cibus Inc Borsa (CBUS) Ultime notizie
Cibus Market Sentiment - Benzinga
Cibus Inc (CBUS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
888,124 Shares in Cibus, Inc. $CBUS Bought by Weiss Asset Management LP - MarketBeat
Cibus Inc (CBUS) Cash Flow - TradingKey
Cibus Inc (CBUS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cibus Inc (CBUS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CBUS|Cibus Inc|Price:1.700|Chg%:-0.080 - TradingKey
Cibus, Inc. Revenue Breakdown – NASDAQ:CBUS - TradingView
TradingKey - TradingKey
Cibus (NASDAQ:CBUS) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
CBUS|Cibus Inc|Price:1.690|Chg%:-0.090 - TradingKey
Cibus Inc (CBUS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cibus Inc (CBUS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CBUS|Cibus Inc|Price:1.780|Chg%:+0.080 - TradingKey
Cibus Inc (CBUS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cibus Inc (CBUS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cibus (NASDAQ:CBUS) Trading 5.7% HigherHere's Why - MarketBeat
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection - Yahoo Finance
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection – Downloadable Initiation Report - Yahoo Finance
Cibus Inc. (CBUS) Surges Over 12% as Momentum Builds at Key LevelsGrowth Stock Picks - dars.gov.et
Cibus (CBUS) Welcomes Landmark EU Crop Breeding Decision - Yahoo Finance
Hagerstown Rotary distributes $55K to local nonprofits - The Herald-Mail
CBUS Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Double-Digit GainsEPS Consistency Score - DonanımHaber
Price to book forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
CBUS Q1 2026 Earnings: Narrower-Than-Expected Loss Amid Ongoing Operational TransitionReturn On Equity - Bölüm Sonu Canavarı
CBUSCibus Inc Options - Finviz
Enterprise value to EBIT forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
Cibus Inc. (CBUS) Edges Higher at $1.36 as Buyers Test Resistance Near $1.43Composite Profile - dars.gov.et
Enterprise value to EBITDA forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
CBUS Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
Cibus, Inc. Class A Actuals & Estimates (NASDAQ:CBUS) - TradingView
Price to earnings forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
Price to sales forward of Cibus, Inc. – NASDAQ:CBUS - TradingView
CBUS Q1 2026 Earnings: Narrow EPS Beat Amid Zero RevenueCFO Commentary Report - dars.gov.et
Cibus Inc (CBUS) Institutional Confidence - TradingKey
Cibus Inc (CBUS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus - The Manila Times
Europe opens fast lane for non-GMO crops; Cibus traits expected to fit - Stock Titan
Cibus Inc. (CBUS) Slides 1.6% as Stock Tests Key Support Near $1.17Merger Arbitrage - newsline.com
CBUS Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineEarnings Volatility Report - DonanımHaber
Cibus names board member Craig Wichner as new CEO - MSN
Cibus (CBUS) CEO receives 894K RSUs and 1.05M stock options grant - Stock Titan
Cibus Inc. (CBUS) Slides 1.63% as Stock Tests Key Support at $1.15Range Breakout - dars.gov.et
Cibus, Inc. Appoints Craig Wichner as CEO to Lead Next Phase of Growth and Innovation in Agricultural Biotechnology - Minichart
Cibus Resets Leadership and Board to Drive Commercialization - TipRanks
Cibus (NASDAQ: CBUS) taps Farmland LP founder Craig Wichner as CEO - Stock Titan
Cibus Names Board Member Craig Wichner as CEO - Moomoo
Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation - The Manila Times
Cibus appoints Craig Wichner as chief executive officer By Investing.com - Investing.com Australia
Cibus (CBUS) Announces Leadership Changes - GuruFocus
Cibus Inc Azioni (CBUS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):